Isabella Ciccone, Assistant Editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter @iciccone7 or email her at firstname.lastname@example.org
Nonpharmacologic Interventions Improve Sleep Time in Hospitalized PatientsOctober 3rd 2022
Findings from a nonrandomized controlled trial in the Netherlands suggest that sleep time of hospitalized patients may be significantly improved with nonpharmacologic interventions such as the postponement of morning vital sign checks and medication administration rounds from the night to the day shift.
Electroacupuncture for Insomnia Significantly Improves Quality of Sleep in Patients With DepressionSeptember 30th 2022
In a randomized clinical trial, the application of electroacupuncture treatment for insomnia in patients with depression significantly improved the quality of sleep in comparison with sham acupuncture or the control group.
Sleep Breathing Disorders Appear Common for Patients with Duchenne Muscular DystrophySeptember 30th 2022
A questionnaire-based study from Saudi Arabia on sleep quality revealed that sleep-related disorders, such as obstructive sleep apnea, are relatively common in patients with Duchenne muscular dystrophy.
Diagnosis of Myotonic Dystrophy Demonstrates an Association With DepressionSeptember 29th 2022
Findings from a cross-sectional survey revealed a significant association between depression and a diagnosis of myotonic dystrophy, and that symptoms impacting quality of life are more common in neuromuscular disorders.
Tollgate-Related Prognostic Factors Have Stronger Effect on ALS Progression Timing Through Disease TollgatesSeptember 28th 2022
A study on ALS progression suggested that tollgate-related prognostic factors have a stronger effect on the time trajectories of passing ALS tollgates in comparison with standard prognostic factors.
Virtual Reality Training May Improve Quality of Care in Lower Limb Spasticity With OnabotulinumtoxinASeptember 27th 2022
Results from pilot program using a VR-based platform suggest medical trainees may benefit from further VR training to gain a complete baseline knowledge of treating lower limb spasticity with onabotulinumtoxinA.
Repetitive Nerve Stimulation Exhibits Positive Association with Inpatient Diagnosis of Myasthenia GravisSeptember 24th 2022
Findings from retrospective study show that repetitive nerve stimulation is a highly sensitive and specific test for the diagnosis of myasthenia gravis in an inpatient setting, with its results being more rapidly available in comparison with antibody testing.
Eplontersin Treatment Results in Reduction in Serum Transthyretin in AmyloidosisSeptember 23rd 2022
Eplontersen treatment resulted in a significant reduction in transthyretin, neuropathy impairment, and improvement in quality of life in the phase 3 NEURO-TTRansform study of patients with hereditary transthyretin amyloidosis.
Pooled Clinical Trial Data Suggests Antidrug Antibody Testing for Alglucosidase Alfa-Exposed Patients With Pompe DiseaseSeptember 23rd 2022
Investigators concluded that those receiving avalglucosidase alfa should be tested for antidrug antibodies by physicians who treat Pompe disease and monitor antidrug antibody, according to a recent Sanofi investigation.
Cipaglucosidase Alfa/Miglustat Shows Beneficial Treatment Effects for Patients With Late-onset Pompe DiseaseSeptember 21st 2022
Most ambulatory patients had improved pulmonary functions and biomarker outcomes with cipaglucosidase alfa/miglustat that were sustained through a less than 36-month follow-up period.
Endovascular Therapy Shows Better Functional Outcomes for Acute StrokeSeptember 21st 2022
A trial conducted in Japan showed better functional outcomes for patients with large cerebral infarctions treated with endovascular therapy than those treated with medical care alone, but had more intracranial hemorrhages.
Remote Yoga Program Feasible and Benefits Individuals with Functional Neurological DisorderSeptember 17th 2022
Danielle Kipnis, MA, of Columbia University, discussed key components of a yoga program for individuals with functional neurological disorder and from the evaluation, found it feasibility as an intervention.
US Preventive Services Task Force Recommends Behavioral Counseling Interventions as a Prevention Method for Adults Without Cardiovascular Disease Risk FactorsSeptember 16th 2022
According to a recommendation from the US Preventive Services Task Force, clinicians should individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.